Rituximab Reference vs Biosimilar Utilization for Oncology vs Nononcology Indications

Reporting on the real-world utilization of reference rituximab and its biosimilars can help show prescribing habits and reveal cost-saving opportunities.

Related Keywords

United States ,Kesselheim ,Rheinland Pfalz ,Germany ,Canada ,Canadian ,Rituximab Rituxan ,Bonniea Labdi ,J Health Syst Pharm ,Long Island University Pharmacy ,Margolis Center ,Duke University ,Association For Accessible Medicines ,Craneware Group ,International Statistical Classification Of Diseases ,Life Sciences ,Trisus Medication Compare ,International Statistical Classification ,Tenth Revision ,Appendix Table ,Quarterly Utilization ,Biosimilar Product ,Deerfield Beach ,Health Policy ,Updated April ,Manag Care Spec ,Rituximab ,Biosimilar ,Oncology ,Utilization ,